Go to main content

Biography Frank Bellivier

Prof. Frank Bellivier

Pr Frank BELLIVIER, Head of the Department of Psychiatry and Addictology at the Saint-Louis-Lariboisière-Fernand-Widal Hospital Group in Paris, Ministerial Delegate for Mental Health and Psychiatry to the Minister of Health and Prevention. 

Frank Bellivier received his medical degree from the Université René Descartes in Paris in 1996. He completed his training with a PhD in Neuroscience (Université Pierre et Marie Curie, Paris), which he obtained in 2000. He was appointed University Professor in 2006. 

Since 2012, he has been Professor of Adult Psychiatry at the Université de Paris Cité, in charge of the Department of Psychiatry and Addictology at the Groupe Hospitalier Saint- Louis - Lariboisière - F. Widal in Paris. He also heads a research team in neuropsychopharmacology of bipolar disorders and addictions (INSERM UMR-S 1144). 

Since May 2019, he has been Ministerial Delegate for Mental Health and Psychiatry, reporting to the Minister of Health and Prevention. In this capacity, he is responsible for coordinating and monitoring the deployment of the "mental health and psychiatry" roadmap launched in June 2018, which today comprises some 50 actions covering the field of promotion/prevention, the care pathway and the social and civic integration of people with mental disorders and disabilities.

Frank Bellivier's research focuses on genetic vulnerability factors for bipolar disorders and suicidal behavior, and on identifying homogeneous subgroups of these disorders in order to improve biomarker identification. More recently, he has set up a research program on the neuropsychopharmacology of affective disorders and addictions. 

In particular, he coordinates several clinical and basic research projects aimed at identifying predictive biomarkers of lithium response in bipolar disorders. In particular, he is coordinating an ANR (2014) and an H2020 program (2018, https://rlink.eu.com/). More generally, his research team explores factors associated with variability in response to psychotropic drugs in mood disorders and addictions. 

422 scientific articles referenced in pubMed (May 2023, index H=59, over 10,000 citations). 

On https://expertscape.com/ex/bipolar+disorder/p/earth, he is ranked 9th worldwide and 6th in Europe among bipolar disorder researchers.